Muscle Soft Tissue Cancer Center

The US Food and Drug Administration (FDA) has approved two new medications for cancer.

This week, the US Food and Drug Administration (FDA) approved Eisai Inc.'s drug derived from sea sponge for a rare type of soft tissue cancer.

Babies can be born with cancer that developed in the mother’s womb. One such cancer is a disease with a long name: infantile myofibromatosis (IM).

Cancer that either starts in or spreads to the bone can be extremely painful. So can cancers that begin in the muscles or other soft tissue of the body. A relatively new treatment method may bring much needed relief.

After a rigorous battle, Venezuelan president Hugo Chavez has died of cancer. He was 58. Chavez recently returned from Cuba, where he received the fourth and final surgery for cancer described imprecisely as “pelvic cancer.”

The US Food and Drug Administration has approved a medication to treat gastrointestinal stromal tumors (GIST) that can’t be removed with surgery, have spread or no longer respond to existing therapies.

Acute lymphoblastic leukemia (ALL) is the most common blood cancer found in children. It’s diagnosed in nearly 3,000 children in the United States every year and can progress quickly if left untreated. These kids now have a new treatment option.

A cancer you don’t hear about much attacks the tissues that connect digestive organs. These are called GIST, which is easier to say than "gastrointestinal stromal tumors". Scientists have found a drug that helps kicks GIST in the gut.

Cancers that appear in the soft tissues of the body are very rare. In fact, they are seen in only about 5 people out of every 100,000. A recent study looked at the best way to treat this cancer.

Kaposi sarcoma (KS) is a soft-tissue cancer that’s associated with a herpes virus. KS is seen in many people who are HIV positive. The tumors show up as purple, red or brown spots. A new treatment for this condition could be in the works.

Pancreatic cancer is one of the most aggressive. Combination chemotherapy has been the treatment mainstay for advanced disease. Now this approach is being questioned.

People living with HIV (human immunodeficiency virus) are at greater risk of various forms of cancer. In fact, when these cancers appear, it means the virus has turned into full-blown AIDS (acquired immunodeficiency syndrome).

Gastrointestinal stromal tumors (GIST) are known as soft tissue sarcomas. They can appear anywhere along the digestive tract. They most commonly start in the stomach. A new drug to treat GIST is headed for review by the U.S. Food and Drug Administration (FDA).

Drug research takes years of development, and there comes a day when hard data reveals whether the drug actually works the way it did in the lab.

Sometimes when you go to the doctor, you wonder - how do they keep up with all the recent research and treatment options for all of this stuff? How do they know how chemotherapies stack up against each other?

A recent presentation at the American Society of Clinical Oncology expanded on several molecular breakthroughs concerning head and neck cancers, and a team of doctors gave an overview of recent conclusions from their respective fields.

An early study looking at a treatment for cancers involving a certain gene mutation had better results than expected, with findings showing that no traces of cancer are detectable in some of the patients in the drug trial.

Genetic studies in a laboratory favorite, zebrafish , have shown that a pediatric cancer has more than one type of cell involved. Some cancer cells specialize in metastasis while others are content to stay where they are.

Despite being tailor-made for specific targets, some of the newer cancer drugs are useful in other types of cancer. A new kidney cancer drug has shown to be effective in metastatic cancer.

Chemotherapy is effective for cancers that have spread out, but that's a double edged sword. You don't want the drugs harming cells in places without cancer, so it would be nice if you could direct it a little.